KRW169,700.00
2.92% today
Korea, Apr 02, 08:09 am CET
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Celltrion Stock price

KRW169,700.00
-14,300.00 7.77% 1M
-11,456.72 6.32% 6M
-17,800.00 9.49% YTD
-4,627.78 2.65% 1Y
+15,434.31 10.01% 3Y
+221.80 0.13% 5Y
+117,469.83 224.91% 10Y
Korea, Closing price Wed, Apr 02 2025
-5,100.00 2.92%
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Key metrics

Market capitalization KRW35.32t
Enterprise Value KRW36.51t
P/E (TTM) P/E ratio 86.86
EV/FCF (TTM) EV/FCF 50.24
EV/Sales (TTM) EV/Sales 10.26
P/S ratio (TTM) P/S ratio 9.93
P/B ratio (TTM) P/B ratio 2.06
Dividend yield 0.43%
Last dividend (FY23) KRW750.00
Revenue growth (TTM) Revenue growth 63.45%
Revenue (TTM) Revenue KRW3.56t
EBIT (operating result TTM) EBIT KRW492.02b
Free Cash Flow (TTM) Free Cash Flow KRW726.73b
Cash position KRW1.14t
EPS (TTM) EPS KRW2,012.40
P/E forward 33.52
P/S forward 7.86
EV/Sales forward 8.13
Show more

Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Celltrion Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Celltrion forecast:

16x Buy
80%
3x Hold
15%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Celltrion forecast:

Buy
80%
Hold
15%
Sell
5%

Financial data from Celltrion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3,557,304 3,557,304
63% 63%
100%
- Direct Costs 2,049,884 2,049,884
76% 76%
58%
1,507,420 1,507,420
49% 49%
42%
- Selling and Administrative Expenses 397,443 397,443
940% 940%
11%
- Research and Development Expense 199,719 199,719
24% 24%
6%
910,258 910,258
1% 1%
26%
- Depreciation and Amortization 418,242 418,242
70% 70%
12%
EBIT (Operating Income) EBIT 492,016 492,016
24% 24%
14%
Net Profit 422,692 422,692
21% 21%
12%

In millions KRW.

Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Wu-Sung Ki
Employees 2,901
Founded 1991
Website www.celltrion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today